Search

Search Constraints

You searched for: Author/Creator Hubank, Michael

Search Results

1. Optimised ARID1A immunohistochemistry is an accurate predictor of ARID1A mutational status in gynaecological cancers. (20th July 2018)

2. EAPH-05. MOLECULAR PROFILING AND IDENTIFICATION OF TARGETED THERAPIES FOR CHILDREN AND YOUNG ADULTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMOURS IN THE UNITED KINGDOM. Issue 2 (22nd June 2018)

3. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. Issue 26 (10th September 2021)

4. Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours. (February 2022)

5. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. (November 2019)

7. DIPG-41. Multi-omic profiling of patient-derived subclones identifies aggressive cellular subpopulations in paediatric diffuse high-grade gliomas (PDHGGs). (3rd June 2022)

8. A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot. Issue 12 (22nd July 2022)

9. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing. (4th January 2020)

10. MODL-19. DIPG HARBOUR ALTERATIONS TARGETABLE BY MEK INHIBITORS, WITH ACQUIRED RESISTANCE MECHANISMS OVERCOME BY COMBINATORIAL UP- OR DOWN-STREAM INHIBITION. (4th December 2020)